A 43-year-old man had left eye irritation for 2 weeks. He denied trauma, headache, eye discharge, fever, cough, or vomiting; he had mild photophobia and slightly blurred vision. Your Dx?
A 43-year-old man had left eye irritation for 2 weeks. He denied trauma, headache, eye discharge, fever, cough, or vomiting; he had mild photophobia and slightly blurred vision. There was mild bilateral photophobia and consensual photophobia. No swelling, temporal artery tenderness, proptosis, or eye pain with motion.
Your Dx?
FDA Accepts Protocol for Annovis Bio’s Buntanetap Phase 3 Alzheimer Disease Trial
January 9th 2025Buntanetap is an oral molecule designed to inhibit the production of multiple neurotoxic proteins and is under investigation for treatment of Alzheimer Disease, Parkinson’s Disease, and other neurodegenerative diseases.